Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Free webinar: Telepathology: is there added value in LMICs?
Free webinar: Telepathology: is there added value in LMICs?

Oncolytic virotherapy using coxsackie virus

Dr Hardev Pandha - University of Surrey, Guildford, UK
Oncolytic virotherapy using coxsackie virus ( Dr Hardev Pandha - University of Surrey, Guildford, UK )
10 Oct 2016

Results of the Activ8 trial of novel immunotherapy motolimod

Dr Ezra Cohen - UC San Diego, San Diego, USA
Results of the Activ8 trial of novel immunotherapy motolimod ( Dr Ezra Cohen - UC San Diego, San Diego, USA )
10 Oct 2016

Lurbinectedin in PARP resistant breast cancer

Dr Cristina Cruz - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
Lurbinectedin in PARP resistant breast cancer ( Dr Cristina Cruz - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )
10 Oct 2016

Monitoring patterns of care in mCRPC patients with the help of the Cancer Registry

Dr Simon Chowdhury - Guy's Hospital, London, UK
Monitoring patterns of care in mCRPC patients with the help of the Cancer Registry ( Dr Simon Chowdhury - Guy's Hospital, London, UK )
10 Oct 2016

Lurbinectedin in BRCA 1/2 breast cancer

Dr Judith Balmaña - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
Lurbinectedin in BRCA 1/2 breast cancer ( Dr Judith Balmaña - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )
10 Oct 2016

Olaparib and paclitaxel for 2nd line gastric cancer therapy

Dr Yung-Jue Bang - Seoul National University, Seoul, South Korea
Olaparib and paclitaxel for 2nd line gastric cancer therapy ( Dr Yung-Jue Bang - Seoul National University, Seoul, South Korea )
10 Oct 2016

Innovative uses of kinase inhibitors in cancer

Dr Jordi Rodón - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
Innovative uses of kinase inhibitors in cancer ( Dr Jordi Rodón - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )
10 Oct 2016

Comment: Ipilimumab in high risk stage III melanoma

Dr Evandro De Azambuja - ‎Jules Bordet Institute, Brussels, Belgium
Comment: Ipilimumab in high risk stage III melanoma ( Dr Evandro De Azambuja - ‎Jules Bordet Institute, Brussels, Belgium )
10 Oct 2016

Comment: Niraparib for ovarian cancer

Dr Evandro De Azambuja - ‎Jules Bordet Institute, Brussels, Belgium
Comment: Niraparib for ovarian cancer ( Dr Evandro De Azambuja - ‎Jules Bordet Institute, Brussels, Belgium )
10 Oct 2016

Comment: Ribociclib for breast cancer

Dr Evandro De Azambuja - ‎Jules Bordet Institute, Brussels, Belgium
Comment: Ribociclib for breast cancer ( Dr Evandro De Azambuja - ‎Jules Bordet Institute, Brussels, Belgium )
10 Oct 2016

Treating CNS metastases from breast cancer with a peptide/paclitaxel conjugate

Prof Shou-Ching Tang - Augusta University Cancer Center, Augusta USA
Treating CNS metastases from breast cancer with a peptide/paclitaxel conjugate ( Prof Shou-Ching Tang - Augusta University Cancer Center, Augusta USA )
10 Oct 2016

Highlights of ESMO 2016

Dr Andrés Cervantes - ESMO 2016 Scientific Chair
Highlights of ESMO 2016 ( Dr Andrés Cervantes - ESMO 2016 Scientific Chair )
10 Oct 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation